Phase II Evaluation of AHCC for the Eradication of HPV Infections

NCT02405533 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Human Papilloma Virus
Dysplasia
CIN1
CIN2

Interventions

DIETARY_SUPPLEMENT: AHCC 3 grams once a day
OTHER: Placebo

Sponsor

The University of Texas Health Science Center, Houston